Morgan Stanley Acrivon Therapeutics, Inc. Transaction History

Morgan Stanley

  • $1.35 Trillion
  • Q3 2024

A detailed history of Morgan Stanley transactions in Acrivon Therapeutics, Inc. stock. As of the latest transaction made, Morgan Stanley holds 35,914 shares of ACRV stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
35,914
Previous 17,249 108.21%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
N/A
18,665 Added 108.21%
35,914 $0
Q2 2024

Oct 17, 2024
BUY
N/A
6 Added 0.03%
17,249 $0
Q2 2024

Aug 14, 2024
BUY
N/A
6 Added 0.03%
17,249 $0
Q1 2024

Oct 17, 2024
SELL
N/A
-6 Reduced 0.03%
17,243 $0
Q1 2024

Aug 16, 2024
SELL
N/A
-8,388 Reduced 32.73%
17,243 $0
Q1 2024

May 15, 2024
SELL
N/A
-8,388 Reduced 32.73%
17,243 $0
Q4 2023

Aug 16, 2024
BUY
N/A
8,382 Added 48.59%
25,631 $0
Q4 2023

Feb 13, 2024
BUY
N/A
20,688 Added 418.53%
25,631 $0
Q3 2023

Nov 15, 2023
SELL
N/A
-3,562 Reduced 41.88%
4,943 $0
Q2 2023

Aug 14, 2023
BUY
N/A
2,881 Added 51.23%
8,505 $0
Q1 2023

May 15, 2023
BUY
N/A
4,755 Added 547.18%
5,624 $0
Q4 2022

Feb 14, 2023
BUY
N/A
869 New
869 $0

Others Institutions Holding ACRV

# of Institutions
53
Shares Held
23.2M
Call Options Held
0
Put Options Held
0
View Full List

About Acrivon Therapeutics, Inc.

ACRV Quotes by TradingView
  • Ticker ACRV
More about ACRV
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email